Pharmacologically inducing regenerative cardiac cells by small molecule drugs
Adult mammals, unlike some lower organisms, lack the ability to regenerate damaged hearts through cardiomyocytes (CMs) dedifferentiation into cells with regenerative capacity. Developing conditions to induce such naturally unavailable cells with potential to proliferate and differentiate into CMs, t...
        Saved in:
      
    
          | Main Authors: | Wei Zhou, Kezhang He, Chiyin Wang, Pengqi Wang, Dan Wang, Bowen Wang, Han Geng, Hong Lian, Tianhua Ma, Yu Nie, Sheng Ding | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | eLife Sciences Publications Ltd
    
        2024-12-01 | 
| Series: | eLife | 
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/93405 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Regenerative therapies for myocardial infarction: exploring the critical role of energy metabolism in achieving cardiac repair        
                          
 by: Jiahao Ren, et al.
 Published: (2025-02-01)
- 
                
                    Using Small Molecules to Reprogram RPE Cells in Regenerative Medicine for Degenerative Eye Disease        
                          
 by: Lyubov A. Rzhanova, et al.
 Published: (2024-11-01)
- 
                
                    Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species        
                          
 by: Juntao Fang, et al.
 Published: (2024-01-01)
- 
                
                    Nanoplastics induces arrhythmia in human stem-cells derived cardiomyocytes        
                          
 by: Shirley Pei Shan Chia, et al.
 Published: (2025-01-01)
- 
                
                    ZEB1-AS1 as a TRPML1 Inhibitor to Cause Lysosome Dysfunction and Cardiac Damage in Aged Mice        
                          
 by: Heng Liu, et al.
 Published: (2024-12-01)
 
       